Economic Atlas
Companies/Delcath Systems, Inc.
Company profile

Delcath Systems, Inc.

NASDAQ: DCTH · Healthcare · Medical - Devices
PublicHQ New York City, NY · New YorkCIK 0000872912Reports USD
#367 of 1,422 Healthcare companies by revenuetop-quartile growth
EA Score
72B
Revenue TTM
$90.4M
Rev growth YoY (TTM)
+67.9%
Net income (FY)
$2.7M
Employees
156
as of 2026-08-12
Market cap
$594.5M
as of 2026-08-12

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$85.2M$85.2M2025
Net income$2.7M$2.7M2025
Operating income$660.0k$660.0k2025
Total assets$123.6M$123.6M2025
Liabilities$12.4M$12.4M2025
Equity$111.2M$111.2M2025

Revenue trend

FY2013 – FY2025 · USD
FY13
FY14
FY15
FY22
FY22
FY23
FY24
FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Delcath Systems, Inc.’s revenue?

Delcath Systems, Inc. booked $85.2M in FY2025 revenue, growing 129% year over year — faster than most Healthcare companies we track, at a 3.2% net margin.

Peers · Healthcare
Harvard Bioscience, Inc.58C4Front Ventures Corp.——Standard BioTools Inc.61C4D Molecular Therapeutics, Inc.58CARS Pharmaceuticals, Inc.41DNurix Therapeutics, Inc.53D
Neighbors
New York →
JPMorgan Chase & Co.$182.4B72BMorgan Stanley$34.3B61CThe Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86AAmerican Express Company$41.3B78B+Citigroup Inc.$85.2B55C
Key facts
CEOGerard J. Michel
SectorHealthcare
IndustryMedical - Devices
HeadquartersNew York City, NY
ExchangeNASDAQ: DCTH
Employees156
IPO date2018-05-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.